Phase I/II Trial of Abraxane [paclitaxel] in Combination with Carboplatin, Erbitux [cetuximab] and Intensity Modulated Radiation Therapy (IMRT) for Treatment of Locally Advanced Squamous Cancer of the Head and Neck
Phase of Trial: Phase I/II
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin; Cetuximab
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Jun 2017 Status changed from completed to discontinued.
- 18 Oct 2016 Status changed from active, no longer recruiting to completed.
- 09 Mar 2016 Planned End Date changed from 1 Dec 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.